Early research (Phase 1)Study completedNCT07495007
What this trial is testing
An Open-label, Randomized, Single-dose, Two-treatment, Four-period, Fully Replicate Crossover Bioequivalence Study in Healthy Female Adult Participants Under Fasting Conditions Comparing the Test Product, Prontogest Solution for IM Injection With the Reference Product, Progesterone Injection
Who this might be right for
BioequivalancePost-menopause
Zi Diligence Biocenter 26